BridgeMD
New treatment option for Stroke Recurrence
Official title Mobile Health Dietary Intervention for Stroke Survivors With Prediabetes or Type 2 Diabetes
ClinicalTrials.gov ID: NCT07120334
What this study is testing
- What it's testing
- Objectives: This study aims to test whether a mobile app called PortionSize Ed can help adults who have had a recent stroke and also have prediabetes or type 2 diabetes improve their diet. Specifically, we want to see if the app can help people follow a Mediterranean-style diet, which may lower the risk of future strokes and improve overall health.
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 65
You may be able to join if
- Aged 30 to 65 years
- Recent stroke (ischemic, hemorrhagic or Transient Ischemic Attack), within 1-14 days prior to enrollment
- Confirmed diagnosis of prediabetes or type 2 diabetes, based on HbA1c results
- Medically stable and cleared for oral diet and physical activity by the attending physician
- Cleared for thin liquids and regular textures by physician
You likely can't join if
- Severe dysphagia that prevents oral intake
- Type 1 diabetes
- Cognitive impairment (e.g., dementia, post-stroke confusion) that precludes consent or compliance, as judged by the clinical care team
- Current participation in another treatment clinical trial
- Pregnant or breastfeeding, or planning to become pregnant during the study period
- Unwilling or unable to provide written informed consent
See the full eligibility criteria
- Aged 30 to 65 years
- Recent stroke (ischemic, hemorrhagic or Transient Ischemic Attack), within 1-14 days prior to enrollment
- Confirmed diagnosis of prediabetes or type 2 diabetes, based on HbA1c results
- Medically stable and cleared for oral diet and physical activity by the attending physician
- Cleared for thin liquids and regular textures by physician
- Capable of providing informed consent
- Able to speak and read English
- Owns a smartphone OR is willing to use a study-provided iPhone
- Has sufficient cognitive and physical function to use a mobile app
- Willing to participate in all study procedures and available for the 12-week duration
- Severe dysphagia that prevents oral intake
- Type 1 diabetes
- Cognitive impairment (e.g., dementia, post-stroke confusion) that precludes consent or compliance, as judged by the clinical care team
- Current participation in another treatment clinical trial
- Pregnant or breastfeeding, or planning to become pregnant during the study period
- Unwilling or unable to provide written informed consent
- Serious comorbid conditions that, in the opinion of the
The study team makes the final eligibility decision.
Where it's taking place
- Honolulu, Hawaii, United States
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Honolulu, Hawaii, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.